Tag: medullaryBreastCancer
Medullary breast cancer: A subtype of ductal breast cancer that also starts in the milk ducts, however the tumor cells resemble the medulla (gray matter) of the brain.
Articles
News
Studies
-
Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base
Cite
Mateo AM, Pezzi TA, Sundermeyer M, Kelley CA, Klimberg VS, Pezzi CM. Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base. Journal of Surgical Oncology. Wiley; 2016; 114:533-536 10.1002/jso.24367
-
Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma
Cite
Chu Z, Lin H, Liang X, Huang R, Tang J, Bao Y, et al. Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma. Japanese Journal of Clinical Oncology. Oxford University Press (OUP); 2015; 45:637-641 10.1093/jjco/hyv052
-
Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome
Cite
Montagna E, Maisonneuve P, Rotmensz N, Cancello G, Iorfida M, Balduzzi A, et al. Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome. Clinical Breast Cancer. Elsevier BV; 2013; 13:31-39 10.1016/j.clbc.2012.09.002
-
Triple negative breast carcinoma: the good, the bad and the ugly
Cite
Kandil D, Khan A. Triple negative breast carcinoma: the good, the bad and the ugly. Diagnostic Histopathology. Elsevier BV; 2012; 18:210-216 10.1016/j.mpdhp.2012.02.001
-
Influence of uncommon histology on breast conservation therapy for breast cancer-biology dictates technique?
Cite
Wasif N, McCullough AE, Gray RJ, Pockaj BA. Influence of uncommon histology on breast conservation therapy for breast cancer-biology dictates technique?. Journal of Surgical Oncology. Wiley; 2011; 105:586-590 10.1002/jso.22132
-
Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark
Cite
Christiansen P, Bjerre K, Ejlertsen B, Jensen M, Rasmussen BB, Laenkholm A, et al. Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 103:1363-1372 10.1093/jnci/djr299
-
Pathologic features, clinical outcomes, and treatment patterns of early-stage triple-negative (TN) breast cancer in an Australian population.
Cite
Seah J, Chionh FJ, Chakrabarti A, Deb S, White S. Pathologic features, clinical outcomes, and treatment patterns of early-stage triple-negative (TN) breast cancer in an Australian population.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11102-e11102 10.1200/jco.2010.28.15_suppl.e11102
-
Prognosis of medullary breast cancer: Analyses of 13 International Breast Cancer Study Group (IBCSG) trials.
Cite
Huober JB, Gelber S, Thürlimann B, Regan MM, Price KN, Goldhirsch A, et al. Prognosis of medullary breast cancer: Analyses of 13 International Breast Cancer Study Group (IBCSG) trials.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:630-630 10.1200/jco.2010.28.15_suppl.630